Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

First reported September 23, 2026 by TechCrunch · covered by 2 sources

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

Sep 23, 2026 · byTechCrunch

Enveda secures $311M to advance nature-derived AI drugs into trials

Enveda's funding boost could accelerate AI-driven drug discovery, potentially transforming pharmaceutical development and enhancing global healthcare. The post Enveda secures $311M to advance nature-derived AI drugs into trials appeared first on Crypto Briefing .

Sep 23, 2026 · byCryptoBriefing